BPD Health

New AI-powered model unifies and integrates all aspects of health system growth.

Both entities are part of MJH Life Sciences. The goal is to offer more services and insights in marketing and communications for healthcare and life sciences brands.

In this video discussion with Chief Healthcare Executive, the CEOs of MJH Life Sciences and BPD Healthcare discuss how the deal came together and what it means for healthcare executives navigating an increasingly complex marketplace.

“This is about building a powerful bridge between the science that transforms lives and the systems that deliver that transformation,” said Michael J. Hennessy Jr., MJH Life Sciences chairman and CEO, of the BPD Healthcare acquisition.